91 / 1084
•
Propensity score match
Preoperative
Chemoradiation
Planned Esophagectomy
442 ptz available
multi-center (10 Europe)
resectable Esophageal or GEJ Siewert type I and II
(stage II or III) , adenocarcinoma 100%
•
3-year overall survival
57.9% versus 53.4%;
Markar SR et al – Ann Oncol - 2016
(Ireland)
HR= 0.89, 95%C.I. 0.67-1.17, p = 0.391
•
disease-free survival
52.9% versus 48.9%;
HR = 0.90, 95%C.I. 0.69-1.18, p = 0.443
Evaluation period 2001-2012; follow-up until 2015